Literature DB >> 22109332

Impact of quantitatively determined native thoracic aortic tortuosity on endoleak development after thoracic endovascular aortic repair.

Takuya Ueda1, Hiroyuki Takaoka, Bhargav Raman, Jarrett Rosenberg, Geoffrey D Rubin.   

Abstract

OBJECTIVE: The objective of our study was to assess whether there is an association between native thoracic aortic curvature and the development of endoleaks after thoracic endovascular aortic repair.
MATERIALS AND METHODS: Quantitative analysis of the native aortic lumen was performed on preprocedural CT angiograms of 40 patients with thoracic aortic aneurysm treated by thoracic endovascular aortic repair. The curvature of the median centerline was measured. Tortuosity indexes were calculated on the basis of the sum of the curvature values within the diseased segment and in the proximal and distal fixation zones. The association between the tortuosity index and endoleak was analyzed.
RESULTS: Compared with patients without endoleaks, the tortuosity index of the proximal fixation zone was higher in patients with type Ia endoleak (9.5 vs 1.5 cm(-1), p < 0.01); the tortuosity index of the distal fixation zone was higher in type Ib endoleak patients (6.6 vs 0.5 cm(-1), p < 0.05); and the tortuosity indexes of the proximal fixation zone and of the diseased segment were higher in type III endoleak patients (11.0 vs 1.5 cm(-1), p < 0.01; and 15.8 vs 7.2 cm(-1), p < 0.01, respectively). Patients with a type III endoleak had longer diseased segments and larger mean diameters of the aneurysm than patients without endoleaks (148.6 vs 87.1 mm, p < 0.01; and 75.4 vs 63.2 mm, p < 0.05, respectively). Logistic regression analysis revealed that the risk of a type I or type III endoleak increased as the tortuosity index increased, with a 90% risk of endoleak at a tortuosity index of 10 cm(-1) in the proximal fixation zone.
CONCLUSION: Quantification of aortic tortuosity using CT angiograms may help to predict whether an endoleak will develop after thoracic endovascular aortic repair, and this quantification method may become an important tool for risk stratification before thoracic endovascular aortic repair.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22109332     DOI: 10.2214/AJR.11.6819

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Tortuosity of the Descending Thoracic Aorta in Patients with Aneurysm and Type B Dissection.

Authors:  Viony M Belvroy; Hector W L de Beaufort; Joost A van Herwaarden; Jean Bismuth; Gabriele Piffaretti; Frans L Moll; Santi Trimarchi
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

2.  Aortic morphometry at endograft position as assessed by 3D image analysis affects risk of type I endoleak formation after TEVAR.

Authors:  Drosos Kotelis; Carolin Brenke; Stefan Wörz; Fabian Rengier; Karl Rohr; Hans-Ulrich Kauczor; Dittmar Böckler; Hendrik von Tengg-Kobligk
Journal:  Langenbecks Arch Surg       Date:  2015-02-22       Impact factor: 3.445

3.  Quantification of motion of the thoracic aorta after ascending aortic repair of type-A dissection.

Authors:  Ga-Young Suh; Dominik Fleischmann; Ramin E Beygui; Christopher P Cheng
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-11-23       Impact factor: 2.924

4.  A Deep Learning-Based and Fully Automated Pipeline for Thoracic Aorta Geometric Analysis and Planning for Endovascular Repair from Computed Tomography.

Authors:  Simone Saitta; Francesco Sturla; Alessandro Caimi; Alessandra Riva; Maria Chiara Palumbo; Giovanni Nano; Emiliano Votta; Alessandro Della Corte; Mattia Glauber; Dante Chiappino; Massimiliano M Marrocco-Trischitta; Alberto Redaelli
Journal:  J Digit Imaging       Date:  2022-01-26       Impact factor: 4.056

5.  Association of arterial stiffness with aortic calcification and tortuosity.

Authors:  Inki Moon; Kwang Nam Jin; Hack-Lyoung Kim; Hyeon Jeong Suh; Woo-Hyun Lim; Jae-Bin Seo; Sang-Hyun Kim; Joo-Hee Zo; Myung-A Kim
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.